1 of 1
Story summary
- Novo Nordisk announced price reductions for Wegovy and Ozempic, effective November 17, 2025.
- The cash price drops to $349 per month from $499.
- New patients can access the two lowest doses for $199 through March 31, 2026.
- The move follows agreements with the administration of U.S. President Donald Trump to improve affordability.
- Pricing remains high at $1,349 for Wegovy and $998 for Ozempic.
